Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
Oncolytic viruses represent a diverse class of replication competent viruses that curtail tumor growth. These viruses, through their natural ability or through genetic modifications, can selectively replicate within tumor cells and induce cell death while leaving normal cells intact. Apart from the...
Main Authors: | Karishma R. Rajani, Richard G. Vile |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/7/11/2914 |
Similar Items
-
Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors
by: D. I. Yudin, et al.
Published: (2020-07-01) -
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study
by: Dimitrios Daoussis, et al.
Published: (2020-01-01) -
Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1
by: Yi-Chi eKong, et al.
Published: (2014-05-01) -
Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
by: Jianmin Wu, et al.
Published: (2021-06-01) -
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
by: Chuzi S, et al.
Published: (2017-06-01)